Keigo Yoshinaga

Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.

Masayoshi Shichiri, Keigo Yoshinaga, Hisashi Hisatomi et al. · PubMed · 2002 · 177 citations

Medicine, Genetics, Oncology +17

A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.

Tetsuro Higuchi, Takeo Iwama∥, Keigo Yoshinaga et al. · PubMed · 2003 · 153 citations

Pharmacy, Pharmacology, Pharmacotherapy +10

Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

Ryo Ohno, Keigo Yoshinaga, Takeshi Fujita et al. · Cancer · 2001 · 135 citations

Medicine, Oncology, Pathology +14

Discontinuous Rectal Cancer Spread in the Mesorectum and the Optimal Distal Clearance Margin in Situ

Chihiro Ono, Keigo Yoshinaga, Masayuki Enomoto et al. · Diseases of the Colon & Rectum · 2002 · 104 citations

Medicine, Oncology, Surgery +17

Neurotensin stimulates growth of colonic mucosa in young and aged rats

B. Mark Evers, Masaaki Izukura, Dai H. Chung et al. · Gastroenterology · 1992 · 85 citations · Full text

Life Sciences, Endocrinology, Physiology +9